Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057629 · ClinicalTrials.gov registry record · Phase 2
Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault
A Phase 2 study of Stress Disorders, Post-Traumatic, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 187
- Enrollment target
- 2
- Study locations
NCT00057629 is a Phase 2 study of Stress Disorders, Post-Traumatic that has completed, run by University of Pennsylvania. The registered enrollment target is 187 participants, above the 153-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (22% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT00057629, a Phase 2 study of Stress Disorders, Post-Traumatic, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 187 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will evaluate the effectiveness of a brief cognitive behavioral therapy, administered by community agencies, for the treatment of patients with Post Traumatic Stress Disorder (PTSD).
Conditions Studied
Interventions
- BEHAVIORAL Prolonged Exposure (PE)
- BEHAVIORAL Treatment as usual group therapy (TUGT)
- BEHAVIORAL Supportive counseling (SC)
Study Locations (2)
Pennsylvania
- Center for the Treatment and Study of Anxiety, University of Pennsylvania - Philadelphia
- Women Organized Against Rape (WOAR) - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2002-01 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00057629
The ClinicalTrials.gov registry entry for NCT00057629 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 153-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (22% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which Prolonged Exposure (PE) is the first listed.
NCT00057629 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00057629 about?
NCT00057629 is a clinical study titled "Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault". This study will evaluate the effectiveness of a brief cognitive behavioral therapy, administered by community agencies, for the treatment of patients with Post Traumatic Stress Disorder (PTSD).
What is the current status of trial NCT00057629?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 187 participants. The study started on 2002-01. Estimated completion is 2009-08.
What conditions does trial NCT00057629 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT00057629?
The interventions under investigation include: Prolonged Exposure (PE) (BEHAVIORAL), Treatment as usual group therapy (TUGT) (BEHAVIORAL), Supportive counseling (SC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00057629?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00057629 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MDMA for Co-occurring PTSD and OUD After Childbirth
RECRUITING · Phase 2
-
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
RECRUITING · Phase 2
-
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
ACTIVE NOT RECRUITING · Phase 2
-
Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
COMPLETED · Phase 2
-
Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.